|
Formulary
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Multiple sclerosis.(Drug Watch: A HEADS-UP ON PHARMACEUTICALS IN LATE-...
February 01, 2008
Luvox CR.(Jazz Pharmaceuticals)(Approvable designations)(Drug overview...
February 01, 2008
Dalbavancin (Pfizer) for the treatment of complicated skin and skin-st...
February 01, 2008
Bazedoxifene (Wyeth) for the prevention of postmenopausal osteoporosis...
February 01, 2008
Cervarix.(Complete response letter)(Drug overview)(Brief article)
February 01, 2008
Valstar.(Nonapprovable designations)(Drug overview)(Brief article)
February 01, 2008
Xcytrin.(Nonapprovable designations)(Drug overview)(Brief article)
February 01, 2008
COL-003 (Collegium) for the management of moderate-to-severe pain.(Fas...
February 01, 2008
CDX-110 (Celldex) for the treatment of EGFRvIII-expressing glioblastom...
February 01, 2008
Bystolic: Nebivolol.(New molecular entity)(Drug overview)
February 01, 2008
Sugammadex (Schering-Plough) for reversal of the effects of rocuronium...
February 01, 2008
Iplex.(Orphan drug designations)(Drug overview)(Brief article)
February 01, 2008
A-001 (Anthera) for the prevention of acute chest syndrome.(Orphan dru...
February 01, 2008
Beclomethasone (Oral BDP, Dot) for the treatment of pediatric Crohn's ...
February 01, 2008
Clobazam (Ovation) as adjunctive treatment for Lennox-Gastaut syndrome...
February 01, 2008
Fludarabine tablets (Xanthus) for the treatment of B-cell chronic lymp...
February 01, 2008
JZP-8 (Jazz) for the treatment of recurrent acute repetitive seizures....
February 01, 2008
AST-120 (Ocera) for the treatment of pouchitis.(Orphan drug designatio...
February 01, 2008
Tysabri: Natalizumab.(New indication)(Drug overview)
February 01, 2008
Cialis.(FDA actions in brief)(Drug overview)(Brief article)
February 01, 2008
Evicel.(FDA actions in brief)
February 01, 2008
Voluven.(FDA actions in brief)(Drug overview)(Brief article)
February 01, 2008
Thyrogen.(FDA actions in brief)(Drug overview)(Brief article)
February 01, 2008
Diovan.(FDA actions in brief)(Drug overview)(Brief article)
February 01, 2008
Cymbalta.(FDA actions in brief)(Drug overview)(Brief article)
February 01, 2008
Triesence.(FDA actions in brief)(Drug overview)(Brief article)
February 01, 2008
Vyvanse.(FDA actions in brief)(Drug overview)(Brief article)
February 01, 2008
Glumetza.(FDA actions in brief)(Drug overview)(Brief article)
February 01, 2008
Sular.(FDA actions in brief)(Drug overview)(Brief article)
February 01, 2008
First-time generic approval.(FDA Drug Approvals)(Drug overview)(Brief ...
February 01, 2008
A review of nonpharmacologic and pharmacologic therapies for smoking c...
February 01, 2008
Ceftobiprole: the first anti-MRSA cephalosporin antibiotic.(Focus on c...
February 01, 2008
Lenalidomide plus dexamethasone demonstrates efficacy in the treatment...
February 01, 2008
Treatment of type 2 diabetes with rosiglitazone associated with increa...
February 01, 2008
Drug development and regulation could be affected by limited resources...
February 01, 2008
|